Developer docs
API playgroundTry for free, no card

Search company profiles

Krebs Biochemicals & Industries

Full company profile

uuid003m1oc

Namestring
Krebs Biochemicals & Industries
Websiteurl
http://krebsbiochem.com/
Company typeenum
Private
Founded yearint
1991
Ownership categoryenum
Headcount rangeband
101–250
akta.pro rankint
HeadquartersHyderabad, India
HQ citystring
Hyderabad
HQ countrystring
India
HQ regionstring
Asia
Markets served

Serves global market

No data
No data
Differentiator
Functional benefit
Problem solved
No data
Market position
Customer concentration

Classification, Details

No data
API detail

Docs URL, Description

AI maturity
App detail

Has app

Core technology
Revenue estimate
Valuation estimate
Number of profiles
No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Krebs Biochemicals & Industries

krebsbiochem.com

Krebs Biochemicals & Industries firmographics

Firmographics
Name
Krebs Biochemicals & Industries
Website
http://krebsbiochem.com/
Company type
Private
Founded year
1991
Headcount range
101–250 employees
Ownership category
akta.pro rank

Where Krebs Biochemicals & Industries is headquartered

Location

Headquarters

HQ city
Hyderabad
HQ country
India
HQ region
Asia

Markets served

Krebs Biochemicals & Industries technology and API

Technology

API detail

API docs
API detail

Core technology

AI maturity

App detail

Krebs Biochemicals & Industries competitors and assessment

Company assessment

Market position

Customer concentration

Krebs Biochemicals & Industries social profiles

Digital presence

Krebs Biochemicals & Industries financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Krebs Biochemicals & Industries leadership team

Management profile

Number of profiles

Krebs Biochemicals & Industries funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Krebs Biochemicals & Industries M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Krebs Biochemicals & Industries

When was Krebs Biochemicals & Industries founded?

Krebs Biochemicals & Industries was founded in 1991. It employs 101 to 250 people.

Where is Krebs Biochemicals & Industries based?

Krebs Biochemicals & Industries is headquartered in Hyderabad, India, in the Asia region.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
ScanXKrebs Biochemicals holds 34th AGM, approves reappointments and RPTsKrebs Biochemicals & Industries held its 34th AGM via video conference on September 29, 2026, and approved the adoption of FY26 audited financial statements. The meeting also ratified the reappointment of Dr. R T Ravi and Mr. Manish Kumar Jain as directors and approved related party transactions with Ipcia Laboratories Limited.Business News TodayKrebs Biochem Standalone June 2026 Net Sales at Rs 6.98 crore, up 27.42% Y-o-Y- Moneycontrol.comKrebs Biochemicals & Industries reported standalone net sales of Rs 6.98 crore for June 2026, a 27.42% increase year-on-year from Rs 5.48 crore in June 2025. The company narrowed its net loss to Rs 2.48 crore from Rs 5.32 crore in the year-ago period, while EBITDA turned positive at Rs 0.99 crore compared to a loss of Rs 2.07 crore previously.ScanXKrebs Biochemicals Q1 Results: Net loss narrows to ₹248 lakh as revenue risesKrebs Biochemicals & Industries Ltd reported Q1FY27 results showing a net loss of ₹248.48 lakh, significantly narrower than the ₹532.43 lakh loss recorded in Q1FY26. Revenue grew 30% year-on-year to ₹714 lakh, while basic EPS improved to ₹(1.15) from ₹(2.47). The Board approved the results on August 6, 2026.Business StandardKrebs Biochemicals & Industries reports standalone net loss of Rs 2.48 crore in the June 2026 quarterKrebs Biochemicals & Industries reported a standalone net loss of Rs 2.48 crore for the quarter ended June 2026, improving from a net loss of Rs 5.32 crore in the same quarter of the previous year. Sales rose 27.37% year-over-year to Rs 6.98 crore during the same period. Despite the improved operational performance, the company continued to post losses as operating profit margin turned positive at 11.89% compared to negative 37.96% a year earlier.Financial ExpressKrebs Biochemicals & Industries Share Price Today: Krebs Biochemicals & Industries Stock Price Live NSE/BSE, Krebs Biochemicals & Industries Share Price, Performance, Share Price Returns, HoldingsThe article presents live financial data and performance metrics for Krebs Biochemicals & Industries, including a closing share price of ₹57.38 and a 1-day gain of 5.42%. It details the company's negative earnings per share (-₹7.85) and significant year-to-date decline of 16.65%, alongside upcoming corporate actions such as board meetings and compliance announcements. The text also provides historical return data, holding patterns, and basic corporate information regarding its pharmaceutical sector classification.ScanXKrebs Biochemicals closes trading window until Q1 resultsKrebs Biochemicals & Industries Ltd has closed its trading window from June 30, 2026, until 48 hours after the declaration of its unaudited Q1 results. The restriction applies to promoters, directors, and designated persons in compliance with SEBI regulations. The company will announce the Board meeting date to consider the results at a later date.Business StandardKrebs Biochemicals & Industries reports standalone net loss of Rs 2.34 crore in the March 2026 quarterKrebs Biochemicals & Industries reported a standalone net loss of Rs 2.34 crore for the quarter ended March 2026, significantly narrowing from a net loss of Rs 8.27 crore in the same quarter of the previous year. Quarterly sales rose 11.64% year-on-year to Rs 6.81 crore. For the full year ended March 2026, net loss improved to Rs 16.93 crore from Rs 26.94 crore, though annual sales declined 45.21% to Rs 23.73 crore.Business StandardKrebs Biochemicals & Industries Ltd leads gainers in 'B' groupOn April 6, 2026, several small-cap stocks on the BSE 'B' group recorded significant single-day gains, with Krebs Biochemicals & Industries Ltd posting the largest increase of 20% to Rs 54.72. Alpa Laboratories Ltd, STL Global Ltd, Next Mediaworks Ltd, and Sakuma Exports Ltd rounded out the top five gainers, with percentage increases ranging from 17.50% to 20%. The trading volumes for these stocks varied, with Sakuma Exports recording the highest volume at 19.52 lakh shares against its average daily volume of 5.78 lakh shares.Business StandardKrebs Biochemicals & Industries reports standalone net loss of Rs 3.13 crore in the December 2025 quarterKrebs Biochemicals & Industries reported a standalone net loss of Rs 3.13 crore for the quarter ended December 2025, compared to a net loss of Rs 7.74 crore in the same quarter of the previous year. The company's sales declined 36.62% to Rs 7.27 crore from Rs 11.47 crore year-over-year, reflecting a significant contraction in revenue. While the net loss narrowed compared to the previous year, the substantial revenue decline indicates continued operational challenges for the firm.